Management of Malignant Small Bowel Obstruction

Initial Assessment and Stabilization

The American College of Surgeons recommends immediate surgical consultation for patients with malignant small bowel obstruction, marked leukocytosis, and elevated absolute neutrophil count, as this presentation suggests possible bowel ischemia or perforation requiring urgent intervention 1
The National Comprehensive Cancer Network suggests beginning immediate supportive treatment with intravenous crystalloid fluids to address dehydration and electrolyte imbalances 1
Insertion of a nasogastric tube for decompression is recommended to prevent aspiration pneumonia and relieve symptoms 1
Placement of a Foley catheter is advised to monitor urine output and assess hydration status 1
A CT scan with IV contrast is recommended immediately, which has >90% diagnostic accuracy for bowel obstruction and can identify signs of ischemia 1

The National Comprehensive Cancer Network recommends CT scan with IV contrast as the preferred imaging study to confirm the diagnosis of malignant SBO, identify the level and cause of obstruction, evaluate for signs of ischemia, and determine if there are multiple sites of obstruction 2, 3
Laboratory tests, including complete metabolic panel, renal function tests, lactate levels, and coagulation profile, should be obtained to assess electrolyte abnormalities, dehydration, intestinal ischemia, and prepare for possible surgery 1

The American College of Surgeons suggests that the combination of malignant SBO with marked leukocytosis and elevated ANC strongly suggests strangulation, ischemia, or perforation requiring immediate surgical intervention 1
Surgery should be performed as soon as possible when signs of ischemia or perforation are present, as mortality can reach 25% if delayed 1
The National Comprehensive Cancer Network recommends considering resection and primary anastomosis, intestinal bypass, or stoma creation, depending on the extent of disease and patient's overall status 2, 3, 5

The National Comprehensive Cancer Network suggests pharmacologic management, including opioids for pain control, antiemetics for nausea and vomiting, corticosteroids to reduce inflammation, somatostatin analogs to reduce gastrointestinal secretions, and anticholinergics to reduce secretions and motility 2, 3
Avoiding antiemetics that increase gastrointestinal motility, such as metoclopramide, in complete obstruction is recommended 2, 3
Consideration of venting gastrostomy tube placement for symptom palliation if surgical intervention is not possible is advised 2, 3

The National Comprehensive Cancer Network recommends considering total parenteral nutrition for patients with a life expectancy of months to years to improve quality of life 3

Delaying surgical consultation when signs of ischemia are present should be avoided 1
Using antiemetics that increase gastrointestinal motility in complete obstruction should be avoided 2, 3
Failing to correct electrolyte abnormalities before surgical intervention should be avoided 1
Overlooking the need for nutritional support in patients with malignant SBO should be avoided 6